Dhingra K - Search Results

1

Residual metastatic axillary lymph nodes following neoadjuvant chemotherapy predict disease-free survival in patients with locally advanced breast cancer.

Kuerer HM, Newman LA, Buzdar AU, Hunt KK, Dhingra K, Buchholz TA, Binkley SM, Ames FC, Feig BW, Ross MI, Hortobagyi GN, Singletary SE. Kuerer HM, et al. Among authors: dhingra k. Am J Surg. 1998 Dec;176(6):502-9. doi: 10.1016/s0002-9610(98)00253-0. Am J Surg. 1998. PMID: 9926779 Clinical Trial.

2

Critical evaluation of prognostic factors.

Dhingra K, Hortobagyi GN. Dhingra K, et al. Semin Oncol. 1996 Aug;23(4):436-45. Semin Oncol. 1996. PMID: 8757270 Review.

3

New strategies in locally advanced breast cancer.

Singletary SE, Dhingra K, Yu DH. Singletary SE, et al. Among authors: dhingra k. Cancer Treat Res. 1997;90:253-71. doi: 10.1007/978-1-4615-6165-1_14. Cancer Treat Res. 1997. PMID: 9367088 Review. No abstract available.

4

Pathologic tumor response in the breast following neoadjuvant chemotherapy predicts axillary lymph node status.

Kuerer HM, Newman LA, Buzdar AU, Dhingra K, Hunt KK, Buchholz TA, Binkley SM, Strom EA, Ames FC, Ross MI, Feig BW, McNeese MD, Hortobagyi GN, Singletary SE. Kuerer HM, et al. Among authors: dhingra k. Cancer J Sci Am. 1998 Jul-Aug;4(4):230-6. Cancer J Sci Am. 1998. PMID: 9689981 Clinical Trial.

5

Phase II clinical and pharmacological study of pirarubicin in combination with 5-fluorouracil and cyclophosphamide in metastatic breast cancer.

Dhingra K, Frye D, Newman RA, Walters R, Theriault R, Fraschini G, Smith T, Buzdar A, Hortobagyi GN. Dhingra K, et al. Clin Cancer Res. 1995 Jul;1(7):691-7. Clin Cancer Res. 1995. PMID: 9816034 Clinical Trial.

6

Role of axillary lymph node dissection after tumor downstaging with induction chemotherapy for locally advanced breast cancer.

Kuerer HM, Newman LA, Fornage BD, Dhingra K, Hunt KK, Buzdar AU, Ames FC, Ross MI, Feig BW, Hortobagyi GN, Singletary SE. Kuerer HM, et al. Among authors: dhingra k. Ann Surg Oncol. 1998 Dec;5(8):673-80. doi: 10.1007/BF02303476. Ann Surg Oncol. 1998. PMID: 9869512

7

Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy.

Kuerer HM, Newman LA, Smith TL, Ames FC, Hunt KK, Dhingra K, Theriault RL, Singh G, Binkley SM, Sneige N, Buchholz TA, Ross MI, McNeese MD, Buzdar AU, Hortobagyi GN, Singletary SE. Kuerer HM, et al. Among authors: dhingra k. J Clin Oncol. 1999 Feb;17(2):460-9. doi: 10.1200/JCO.1999.17.2.460. J Clin Oncol. 1999. PMID: 10080586 Clinical Trial.

8

Phase II study of paclitaxel in patients with metastatic breast carcinoma refractory to standard chemotherapy.

Rivera E, Holmes FA, Frye D, Valero V, Theriault RL, Booser D, Walters R, Buzdar AU, Dhingra K, Fraschini G, Hortobagyi GN. Rivera E, et al. Among authors: dhingra k. Cancer. 2000 Dec 1;89(11):2195-201. doi: 10.1002/1097-0142(20001201)89:11<2195::aid-cncr7>3.0.co;2-w. Cancer. 2000. PMID: 11147589 Clinical Trial.

9

Phase II trial of 10-EDAM in the treatment of metastatic breast cancer.

Beinart GA, Gonzalez-Angulo AM, Broglio K, Frye D, Walters R, Holmes FA, Gunale S, Booser D, Rosenthal J, Dhingra K, Young JA, Hortobagyi GN. Beinart GA, et al. Among authors: dhingra k. Cancer Chemother Pharmacol. 2007 Jun;60(1):61-7. doi: 10.1007/s00280-006-0348-9. Epub 2006 Sep 29. Cancer Chemother Pharmacol. 2007. PMID: 17009032 Clinical Trial.

10

Genetic changes in breast cancer--consequences for therapy?

Dhingra K, Hittelman WN, Hortobagyi GN. Dhingra K, et al. Gene. 1995 Jun 14;159(1):59-63. doi: 10.1016/0378-1119(94)00560-f. Gene. 1995. PMID: 7607573 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

210 results

Search Page

Filters